AGL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AGL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Agilon Health's gross profit for the three months ended in Dec. 2024 was $-38 Mil. Agilon Health's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $5 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Agilon Health's gross profit for the three months ended in Dec. 2024 was $-38 Mil. Agilon Health's Revenue for the three months ended in Dec. 2024 was $1,522 Mil. Therefore, Agilon Health's Gross Margin % for the quarter that ended in Dec. 2024 was -2.51%.
Agilon Health had a gross margin of -2.51% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
During the past 6 years, the highest Gross Margin % of Agilon Health was 7.73%. The lowest was 0.08%. And the median was 3.96%.
Warning Sign:
Agilon Health Inc gross margin has been in long-term decline. The average rate of decline per year is -49.1%.
The historical data trend for Agilon Health's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Gross Profit | Get a 7-Day Free Trial | 94.15 | 65.74 | 111.36 | 69.67 | 4.84 |
Agilon Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Gross Profit | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-94.87 | 75.09 | 32.18 | -64.17 | -38.26 |
For the Medical Care Facilities subindustry, Agilon Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Gross Profit distribution charts can be found below:
* The bar in red indicates where Agilon Health's Gross Profit falls into.
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Agilon Health's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as
Gross Profit (A: Dec. 2024 ) | = | Revenue | - | Cost of Goods Sold |
= | 6060.53 | - | 6055.689 | |
= | 5 |
Agilon Health's Gross Profit for the quarter that ended in Dec. 2024 is calculated as
Gross Profit (Q: Dec. 2024 ) | = | Revenue | - | Cost of Goods Sold |
= | 1522.486 | - | 1560.741 | |
= | -38 |
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
Agilon Health's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as
Gross Margin % (Q: Dec. 2024 ) | = | Gross Profit (Q: Dec. 2024 ) | / | Revenue (Q: Dec. 2024 ) |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | -38 | / | 1522.486 | |
= | -2.51 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Agilon Health (NYSE:AGL) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Agilon Health had a gross margin of -2.51% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
Thank you for viewing the detailed overview of Agilon Health's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Karen Mcloughlin | director | COGNIZANT TECHNOLOGY SOLUTIONS, 500 FRANK W. BURR BLVD., TEANECK NJ 07666 |
Silvana Battaglia | director | 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428 |
Diana Mckenzie | director | METLIFE, 200 PARK AVENUE, NEW YORK NY 10166 |
John William Wulf | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Steven Sell | director, officer: CEO & President | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Jeffrey A. Schwaneke | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Benjamin Shaker | officer: Chief Markets Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Timothy Gertsch | officer: Chief Accounting Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Cd&r Investment Associates Ix, Ltd. | 10 percent owner | MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194 |
Veeral Desai | officer: Chief Strategy & Dev. Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Benjamin Kornitzer | officer: Chief Med. & Quality Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Priscilla Kasenchak | officer: Chief Accounting Officer | 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042 |
Michael L Smith | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Theodore Halkias | officer: Chief Business Officer | C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831 |
Joan Danieley | officer: Chief Administrative Officer | C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831 |
From GuruFocus
By Marketwired • 02-17-2025
By GuruFocus News • 02-23-2025
By GuruFocus News • 12-14-2024
By Marketwired • 10-30-2024
By GuruFocus News • 11-07-2024
By GuruFocus News • 11-08-2024
By Business Wire • 02-21-2025
By GuruFocus News • 12-12-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 02-26-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.